Automated description from the Alliance of Genome Resources
Predicted to have DNA-binding transcription factor activity and RNA polymerase II proximal promoter sequence-specific DNA binding activity. Predicted to be involved in negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning and regulation of transcription by RNA polymerase II. Predicted to localize to the nucleus. Orthologous to human RFX8 (RFX family member 8, lacking RFX DNA binding domain).